CRHR1 rs242941: What Your Genotype Means
The rs242941 variant is a single nucleotide polymorphism located within the CRHR1 gene, which plays a key role in the body's stress response system. Research has investigated its potential associations with susceptibility to depression and individual responses to corticosteroid treatments.
What each genotype means
Typical endocrine and stress response
You carry two copies of the G allele for the CRHR1 rs242941 variant. Research suggests this genotype is associated with standard hypothalamic-pituitary-adrenal (HPA) axis cortisol reactivity, though clinical effects are modest and modulated by life stress. In pharmacogenetic respiratory studies, this genotype has also been linked with variable responsiveness to inhaled corticosteroid therapy, but you should discuss any medication management with your healthcare provider.
Carried by approximately 30% to 35% of individuals of European ancestry, and generally more frequent in East Asian populations.
Intermediate stress resilience profile
You carry one copy of the T allele and one copy of the G allele for rs242941. Carrying the minor T allele has been evaluated in studies examining moderation of early-life stress and altered cortisol reactivity, with evidence generally indicating an intermediate endocrine response. Findings across diverse populations remain limited and mixed, meaning this result alone does not determine your physiological stress resilience.
Carried by roughly 45% to 50% of individuals of European ancestry, representing the most common genotype in many populations.
Altered cortisol and stress response
You carry two copies of the minor T allele in the CRHR1 regulatory region. Published research associates this genotype with altered endocrine cortisol release and potential protective moderation against depressive symptoms following childhood adversity, although studies show mixed results across ancestries. Some investigations also observe delayed cortisol suppression following corticosteroid treatment; any concerns about stress regulation or medication response should be evaluated with your doctor.
Carried by approximately 15% to 20% of individuals of European ancestry; less frequent in East Asian cohorts.
Understanding the rs242941 Variant
The rs242941 variant is a specific change in the DNA sequence of the CRHR1 gene. In genetics, a single nucleotide polymorphism, or SNP, represents a variation at a single position in the DNA building blocks. This particular variant is situated within the regulatory regions of the CRHR1 gene, which provides instructions for creating the corticotropin-releasing hormone receptor 1. This receptor is a critical component of the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary system for managing stress. By influencing how this receptor is expressed or functions, the rs242941 variant may subtly alter how an individual's body perceives and reacts to stressful stimuli or hormonal signals. Because it is located in a regulatory area, it does not necessarily change the structure of the protein itself, but rather how much of that protein is produced or when it is activated in response to environmental triggers.
The Role of the CRHR1 Gene
The CRHR1 gene encodes a G-protein coupled receptor that binds to corticotropin-releasing hormone (CRH). This hormone is a central mediator of the stress response, acting as a master switch that triggers a cascade of physiological events, including the release of cortisol from the adrenal glands. When CRH binds to the CRHR1 receptor, it initiates a signaling pathway that helps the body mobilize energy and respond to perceived threats. Because this system is so fundamental to human physiology, variations in the genes that control it, such as CRHR1, are of significant interest to researchers studying mental health and endocrine function. Proper regulation of this receptor is essential for maintaining homeostasis; if the system is either overactive or underactive, it can influence how an individual handles chronic stress, potentially impacting mood regulation and the body's ability to recover from intense physiological demands.
Research Associations and Evidence Strength
Scientific research into rs242941 has produced mixed and sometimes contradictory findings, leading to a classification of limited evidence. Some studies have explored whether this variant influences susceptibility to depression, with meta-analyses suggesting a potential link, though results remain heterogeneous across different populations. Other research has examined the variant's role in medical settings, specifically regarding how patients respond to systemic corticosteroids, such as those used for asthma exacerbations. Some evidence suggests that certain genotypes might be associated with improved respiratory function or altered cortisol responses during treatment. However, it is important to note that these associations are statistical in nature and do not imply a direct cause-and-effect relationship for every individual. Because many of these studies involve relatively small sample sizes or specific ethnic groups, the findings may not be universally applicable. Further large-scale research is required to clarify the clinical significance of this variant.
Population Frequency
The prevalence of the rs242941 variant varies significantly across different global populations. According to data from gnomAD, the minor allele frequency is approximately 0.42 in European ancestry populations, making it a relatively common genetic feature. In other populations, the frequency of the alleles may differ, which is a common observation in human genetics. Because this variant is common, it is considered a normal part of human genetic diversity rather than a rare mutation. Understanding these frequency differences is crucial for researchers, as it helps them account for ancestry-specific patterns when conducting association studies. If you are interested in your own genetic profile, it is helpful to remember that population-level statistics describe groups, not individuals, and your personal health is influenced by a complex interplay of many genes, environmental factors, and lifestyle choices.
What You Can and Cannot Do With This Information
Genetic information like the rs242941 genotype is primarily for educational purposes and should not be used to make medical decisions. You cannot use this information to diagnose a condition, predict your future health, or determine your risk for depression. While some studies suggest associations with medication response, these findings are not currently used in standard clinical practice to guide treatment. If you are currently taking corticosteroids or other medications, never change your dosage or stop your treatment based on genetic test results. Always discuss your health concerns, family history, and any genetic information you have with your clinician or a qualified pharmacist. They are the only ones who can interpret your results in the context of your overall health, medical history, and current treatment plan. Genetic testing provides a piece of the puzzle, but it is never a substitute for professional medical advice and comprehensive clinical evaluation.
How common is this variant?
The minor allele frequency for rs242941 is approximately 0.42 in European ancestry populations according to gnomAD data.
Frequently asked questions
Is rs242941 a cause of depression?
No, rs242941 is not a direct cause of depression. While some studies have found statistical associations between this variant and depression, these results are inconsistent and do not mean that carrying a specific genotype will lead to a mental health condition.
Should I change my asthma medication based on my rs242941 genotype?
No, you should never change your medication or dosage based on genetic test results. Always consult your doctor or pharmacist before making any changes to your prescribed treatment plan.
Does this variant affect my cortisol levels?
Some research suggests that variants in the CRHR1 gene may be associated with variations in cortisol response, but these effects are complex and influenced by many other factors. It is not a simple indicator of your baseline cortisol levels.
Where can I find more information about my specific genotype?
You can discuss your genetic results with a genetic counselor or your primary care physician. They can help you understand the limitations of current research and how it relates to your personal health context.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs242941?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CRHR1
HPA-axis modulating variant in CRHR1 that interacts with psychosocial stress exposure to affect emotional reactivity and stress-coping traits.
Key intronic polymorphism in the corticotropin-releasing hormone receptor 1 gene that moderates endocrine and emotional vulnerability after exposure to early life trauma.
Polymorphism within the CRHR1 locus tagged to haplotypes modulating cortisol release during the Trier Social Stress Test.
Variant in the corticotropin-releasing hormone receptor 1 gene that moderates hypothalamic-pituitary-adrenal axis reactivity and vulnerability to stress-induced mood disturbances.
Intronic CRHR1 variant associated with neuroendocrine stress sensitivity.
Tag variant in the CRHR1 locus associated with HPA axis regulation.